Literature DB >> 4926934

Fluorescent antibody tests for syphilis using cerebrospinal fluid: clinical correlation in 150 cases.

M R Escobar, H P Dalton, M J Allison.   

Abstract

Mesh:

Year:  1970        PMID: 4926934     DOI: 10.1093/ajcp/53.6.886

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  14 in total

1.  VDRL titres in early syphilis before and after treatment.

Authors:  S Talwar; M A Tutakne; V D Tiwari
Journal:  Genitourin Med       Date:  1992-04

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Study of fluorescent treponemal antibody test on cerebrospinal fluid using monospecific anti-immunoglobulin conjugates IgG, IgM, and IgA.

Authors:  G Leclerc; M Giroux; A Birry; S Kasatiya
Journal:  Br J Vener Dis       Date:  1978-10

4.  Syphilis.

Authors:  M A Conant
Journal:  West J Med       Date:  1974-01

5.  Fluorescent treponemal antibody tests on cerebrospinal fluid.

Authors:  A E Wilkinson
Journal:  Br J Vener Dis       Date:  1973-08

Review 6.  Persistence of treponemes after treatment.

Authors:  E M Dunlop
Journal:  Br Med J       Date:  1972-06-03

7.  Fluorescent treponemal antibody-cerebrospinal fluid (FTA-CSF) test. A provisional technique.

Authors:  W P Duncan; T W Jenkins; C E Parham
Journal:  Br J Vener Dis       Date:  1972-04

8.  Neurosyphilis: an update.

Authors:  R P Simon
Journal:  West J Med       Date:  1981-01

Review 9.  Laboratory diagnosis and interpretation of tests for syphilis.

Authors:  S A Larsen; B M Steiner; A H Rudolph
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

10.  Detection of immunoglobulin M in cerebrospinal fluid from syphilis patients by enzyme-linked immunosorbent assay.

Authors:  J B Lee; C E Farshy; E F Hunter; E A Hambie; G H Wobig; S A Larsen
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.